Navigation Links
FASEB SRC announces conference: Matricellular Proteins in Development, Health, and Disease
Date:2/4/2013

Bethesda, MD The Federation of American Societies for Experimental Biology (FASEB) announces the opening of registration for the Science Research Conference (SRC): Matricellular Proteins in Development, Health, and Disease.

Interactions between cells and their surrounding extracellular matrix (ECM) are the basis for multi-cellular life and essential for cell and tissue organization in all metazoan organisms. Structural ECM components such as collagens, fibronectin, and laminins, are secreted by cells and assembled extracellularly into organized sheets (basement membranes) or three-dimensional fibrils and networks (connective tissue matrix). ECM also contains less abundant, but highly regulated, components that play important roles in controlling cell behavior and matrix remodeling. Because of their distinctive localizations and functional attributes in the ECM, these proteins have been termed matricellular proteins and include members of the thrombospondin, CCN, tenascin, osteopontin, periostin, fibulin, and SPARC families.

The purpose of this conference is to focus on these matricellular proteins and to examine their structure-function relationships and their impact on signaling networks that play key roles in disease, homeostasis, repair, and development. The conference format includes lectures and poster sessions and short talks selected from submitted abstracts and late breaking work. The program covers both mechanistic scientific perspectives (Sessions 1-3) and disease specific emphases (Sessions 4-9). Mechanistic sessions will discuss novel regulatory mechanisms of the matricellular proteins and their receptors (Session 1) and the complex roles of matricellular proteins in regulation of multiple growth factors in disease (Session 3), which is an important function of these proteins in homeostasis and disease.

For the first time, we will have a session to highlight mammalian and non-mammalian model systems (Session 2). The long-standing disease focus areas of the field in cardiovascular disease (Session 6), carcinogenesis/angiogenesis (Session 7), and in musculoskeletal development and disease (Session 9) are well represented on the program. In addition, there will be three sessions focusing on emerging areas of intense activity and significant progress in the matricellular field over the past two-three years: inflammation and immunity (Session 4), diabetes and obesity (Session 5), and neurobiology (synapse formation, neuropathic pain) (Session 8).

Inclusion of women, minorities, and young scientists has been emphasized in developing the program. Invited speakers represent leaders in the basic sciences, clinical investigators who are defining the roles of matricellular proteins in the etiology of inherited disorders and several major diseases of adults, and investigators developing novel therapeutics to treat these diseases. The overall objectives of this meeting are to foster new knowledge in the field of matricellular proteins that will lead to development of therapeutics for the treatment of human diseases, facilitate the development of new multidisciplinary collaborations and research directions, and encourage the development of young scientists in this field.

FASEB SRC has announced a total of 34 SRCs in 2013. To register for an SRC, view preliminary programs, or find a listing of all our 2013 SRCs, please visit www.faseb.org/SRC.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Related biology news :

1. FASEB SRC announces conference registration open for: Biology and Chemistry of Vision
2. FASEB SRC announces conference registration open for: Hematologic Malignancies
3. FASEB SRC announces conference registration open for: Mechanisms in Plant Development Conference
4. FASEB SRC announces conference registration open for: Ciliate Molecular Biology
5. FASEB SRC announces conference: Renal Hemodynamics: Integrating with the Nephron & Beyond
6. FASEB SRC announces: Mechanism and Regulation of Prokaryotic Transcription Conference
7. FASEB SRC announces conference registration open: The Biology of Calpains in Health and Disease
8. FASEB SRC announces conference: Gastrointestinal Tract XV: Epithelia, Microbes, Inflammation & Cancer
9. FASEB urges biomedical research community to speak out against sequestration
10. FASEB lauds Air India for transporting research animals
11. Undergraduate Student Summer Research Award recipients announced for the 2012 FASEB MARC summer research opportunity program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... public,s help is being enlisted in what,s thought to be the biggest ... human body –and are believed to affect health.  ... The Microbiome Immunity Project is the largest study to date ... project's goal is to help advance scientific knowledge of the role of ... The ...
(Date:6/14/2017)... , June 15, 2017  IBM (NYSE: IBM ) ... international tech event dedicated to developing collaboration between startups and ... on June 15-17. During the event, nine startups will showcase ... value in various industries. France ... the international market, with a 30 percent increase in the ...
(Date:4/24/2017)... 24, 2017 Janice Kephart , ... Identity Strategy Partners, LLP (IdSP) , today issues ... President Trump,s March 6, 2017 Executive Order: ... vetting can be instilled with greater confidence, enabling ... all refugee applications are suspended by until at ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... Rosalind™, the first-ever genomics analysis platform specifically designed for life science researchers ... honor of pioneering researcher Rosalind Franklin, who made a major contribution to ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... set to take place on 7th and 8th June 2018 in San Francisco, CA. ... policy influencers as well as several distinguished CEOs, board directors and government officials from ...
(Date:10/11/2017)... BioMarketing, a leading provider of patient support solutions, has announced ... network, which will launch this week. The VMS CNEs will ... to enhance the patient care experience by delivering peer-to-peer education ... professionals to help women who have been diagnosed and are ... ...
Breaking Biology Technology: